AU Patent

AU2013328625B2 — Pyrrolobenzodiazepine-antibody conjugates

Assigned to ADC Therapeutics SA · Expires 2016-12-15 · 9y expired

What this patent protects

Conjugates of an antibody that binds to CD25 with PBD dimers.

USPTO Abstract

Conjugates of an antibody that binds to CD25 with PBD dimers.

Drugs covered by this patent

cobimetinib-fumarate (COBIMETINIB FUMARATE)

Patent Metadata

Patent number: AU2013328625B2
Jurisdiction: AU
Classification: —
Expires: 2016-12-15
Drug substance claim: No
Drug product claim: No
Assignee: ADC Therapeutics SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.